Innovent Biologics, Inc.

OTCPK:IVBX.F Stock Report

Market Cap: US$9.4b

Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:IVBX.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 24BuyUS$11,040JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,000US$5.52
11 Sep 24BuyUS$11,040JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany2,000US$5.52
11 Sep 24SellUS$223,559JP Morgan Asset ManagementCompany40,500US$5.52
11 Sep 24SellUS$85,461,245JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany15,482,177US$5.52
10 Sep 24BuyUS$57,544,602JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,624,087US$5.42
10 Jul 24SellUS$12,728,577Capital Research and Management CompanyCompany2,755,000US$4.62
03 May 24SellUS$4,683,731De-Chao YuIndividual906,250US$5.17
02 Feb 24BuyUS$7,773,313Capital Research and Management CompanyCompany1,869,776US$4.16
12 Jan 24BuyUS$6,636,262Capital Research and Management CompanyCompany1,292,500US$5.13
05 Jan 24SellUS$17,121,093Capital Research and Management CompanyCompany3,456,000US$4.95
25 Oct 23BuyUS$13,207,557Capital Research and Management CompanyCompany2,249,500US$5.87
17 Oct 23SellUS$2,842,373De-Chao YuIndividual502,961US$5.65
12 Oct 23SellUS$18,282,217Capital Research and Management CompanyCompany3,324,500US$5.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IVBX.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,614,5000.651%
VC/PE Firms89,475,3505.49%
Individual Insiders114,734,8237.03%
General Public661,130,39140.5%
Institutions755,090,80546.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.95%
Capital Research and Management Company
113,425,003US$653.2m-0.65%0.03%
6.76%
De-Chao Yu
110,253,778US$635.0m0.92%no data
5.49%
SDIC Innovation Investment Management Co., Ltd.
89,475,350US$515.3m0%35.01%
3.58%
The Vanguard Group, Inc.
58,440,486US$336.6m0%no data
3.39%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
55,364,540US$318.9m0%52.05%
2.62%
BlackRock, Inc.
42,678,599US$245.8m-1.42%no data
2.23%
GF Fund Management Co., Ltd.
36,440,000US$209.9m-17.1%0.46%
1.99%
Norges Bank Investment Management
32,441,094US$186.8m116%0.01%
1.85%
Fidelity International Ltd
30,119,499US$173.5m0%0.06%
1.68%
E Fund Management Co., Ltd.
27,411,000US$157.9m0%0.22%
1.66%
Canada Pension Plan Investment Board
27,004,000US$155.5m0%0.03%
1.53%
Citigroup Inc.,Banking and Securities Investments
24,932,063US$143.6m0%0.1%
1.46%
Bosera Asset Management Co., Ltd.
23,872,000US$137.5m-0.63%0.68%
1.44%
Harvest Fund Management Co. Ltd.
23,417,788US$134.9m-9.98%0.31%
0.88%
Lav Advanced Management Company Limited
14,276,500US$82.2m0%81.2%
0.84%
FMR LLC
13,703,461US$78.9m-11.3%no data
0.77%
Temasek Holdings (Private) Limited
12,585,500US$72.5m-57.7%0.05%
0.62%
Schroder Investment Management Limited
10,080,000US$58.1m0%0.03%
0.62%
China Asset Management Co. Ltd.
10,050,251US$57.9m-0.63%0.08%
0.54%
Schroder Investment Management North America Inc.
8,744,500US$50.4m0%0.14%
0.52%
Polar Capital Holdings Plc
8,551,503US$49.3m0%0.17%
0.51%
ICBC Credit Suisse Asset Management Co., Ltd.
8,343,974US$48.1m214%0.26%
0.49%
Invesco Ltd.
8,029,000US$46.2m-1.98%0.01%
0.45%
LAV Investment Adviser Limited
7,345,000US$42.3m0%36.87%
0.43%
JPMorgan Chase & Co, Brokerage and Securities Investments
7,054,321US$40.6m94.9%0.02%